Submicroscopic deletions in the 7q region are associated with recurrent chromosome abnormalities in acute leukemia

Haematologica

Volumn 88, Issue 4, 2003, Pages 429-437

  Basiricò, Rosaria ^b   Pirrotta, Rosa ^b   Fabbiano, Francesco ^b   Mirto, Salvo ^b   Cascio, Lucia ^b   Pagano, Maria ^b   Cammarata, Giuseppe ^b   Magrin, Silvana ^b   Santoro, Alessandra ^a  

^a VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^b NONE

Author keywords

7q region; Acute leukemia; LOH; Recurrent chromosomal aberrations

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CANCER RECURRENCE; CHROMOSOME 7; CHROMOSOME 7Q; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CONTROLLED STUDY; CYTOGENETICS; DISEASE ASSOCIATION; FEMALE; GENE DELETION; HEMATOLOGIC MALIGNANCY; HETEROZYGOSITY LOSS; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; MONOSOMY; NUCLEOTIDE SEQUENCE; PROGNOSIS; PROMOTER REGION; RECURRENT DISEASE; TUMOR SUPPRESSOR GENE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CHILD; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 7; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; LEUKEMIA; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; RECURRENCE; SEQUENCE DELETION;

EID: 0038712176     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Johansson B, Mertens F, Mitelman F. Cytogenetic deletion maps on haematologic neoplasms, circumstantial evidence for tumor suppressor loci. Genes Chromosome Cancer 1993;8: 205-8.
2. Heim S. Cytogenetic findings in primary and secondary MDS. Leukaemia Res 1992;16:43-6.
3. Sandberg AA. The Chromosome in Human Cancer and Leukemia. 1990 Elsevier Science Publishing Co., Inc, New York; USA.
4. Fischer K, Frohling S, Scherer SW, McAllister Brown J, Scholl C, Stingelbauer S, et al. Molecular cytogenetic delineations and traslocations involving chromosome band 7q22 in myeloid leukaemias. Blood 1997;86:2036-41.
5. Johnson EJ, Scherer W, Osborne L, Tsui LC, Oscier D, Mould S, et al. Molecular definition of a narrow internal at 7q22.1 associated with myelodysplasia. Blood 1996;87:3579-86.
6. th International Workshop on Chromosomes in Leukaemia 1982. Cancer Genet Cytogenet 1984;11:300-3.
7. Bloomfield CD, Shuma C, Regal L, Philip PP, Hossfeld DK, Hagemeijer AM, et al. Long-term survival of patients with acute myeloid leukemia: A third follow up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer 1997; 80:2191-8.
8. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 Trial. Blood 1998;92:2322-33.
9. Faderl S, Kantarjian HM, Talpaz M, Estrov Z. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood 1998;91:3995-4019.
10. Wetzler M, Dodge RK, Mròzek K, Carroll AJ, Tantravahi R, Block AM, et al. Prospective karyotype analysis in adult acute lymphoblastic leukemia: the Cancer and Leukemia Group B experience. Blood 1999;93:3983-93.
11. Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukaemia: further evidence for characteristic abnormalities of chromosome nos 5 and 7. J Clin Oncol 1986;3:325-45.
12. Atkin NB, Baker MC. Chromosome 7q deletions: observation on 13 malignant tumors. Cancer Genet Cytogenet 1993;67:123-5.
13. Zenklusen JC, Biéche I, Lidereau R, Conti CJ. CA microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. Proc Natl Acad Sci USA 1994;91:12155-8.
14. Zenklusen JC, Thompson JC, Troncoso P, Kagan J, Conti CJ. Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. Cancer Res 1994; 54:6370-3.
15. Zenklusen JC, Thompson JC, Klein-Szanto AJ, Conti CJ. Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene. Cancer Res 1995;55:1347-50.
16. Hernandez JM, Schoenmakers EF, Dal Cin P, Michaux L, Van de Ven WJ, Van den Berghe H. Molecular delineation of the commonly deleted segment in mature B-cell lymphoid neoplasias with deletion of 7q. Genes Chromosomes Cancer 1997;18:147-50.
17. Koike M, Takeuki S, Yokota J, Park S, Hatta Y, Miller CW, et al. Frequent loss of heterozygosity in the region of the D7S523 locus in advanced ovarian cancer. Genes Chromosomes Cancer 1997;19:1-5.
18. Lin JC, Scherer SW, Tougas L, Traverso G, Tsui LC, Andrulis IL; et al. Detailed deletion mapping with a refined physical map of 7q31 localizes a putative tumor suppressor gene for breast cancer in the region of MET. Oncogene 1996;13:2001-8.
19. Liang H, Fairman J, Claxton DF, Nowell PC, Green ED, Nagarajan L. Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci. Proc Natl Acad Sci USA 1998;95:3781-5.
20. Le Beau MM, Espinosa R, Davis EM, Eisenbart JD, Larson RA, Green ED. Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid disorders. Blood 1996;88:1930-5.
21. Kratz CP, Emerling BM, Donovan S, Laig-Webster M, Taylor BR, Thompson P, et al. Candidate gene isolation and comparative analysis of a commonly deleted segment of 7q22 implicated in myeloid malignancies. Genomics 2001;77:171-80.
22. Thiagalingam S, Foy RL, Cheng KH, Lee HJ, Thiagalingam A, Ponte JF. Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence. Curr Opin Oncol 2002;14:65-72.
23. Tosi S, Scherer SW, Giudici G, Czepulkowski B, Biondi A, Kearney L. Delineation of multiple deleted regions in 7q the long arm of chromosome 7 in human breast cancer defines the location of a second tumor suppressor gene at 7q22 in the region of the CUTL1 gene. Oncogene 1999;18:2015-21.
24. Emerling BM, Bonifas J, Kratz CP, Donovan S, Taylor BR, Green ED, et al. MLL5, a homolog of Drosophila trithorax located within a segment of chromosome band 7q22 implicated in myeloid leukemia. Oncogene 2002;21:4849-54.
25. Kratz CP, Emerling BM, Bonifas J, Wang W, Green ED, Le Beau MM, et al. Genomic structure of the PIK3CG gene on chromosome band 7q22 and evaluation as a candidate myeloid tumor suppressor. Blood 2002;99:372-4.
26. Frohling S, Nakabayashi K, Scherer SW, Dohner H, Dohner K. Mutation analysis of the origin recognition complex subunit 5 (ORC5L) gene in adult patients with myeloid leukemias exhibiting deletions of chromosome band 7q22. Hum Genet 2001;108:304-9.
27. ISCN. An international system for human cytogenetic nomenclature. Basel, Switzerland; Karger. 1995.
28. Zeng WR, Scherer SW, Koutsilieris M, Huizenga JJ, Filteau F, Tsui LC, et al. Loss of heterozygosity and reduced expression of the CUTL1 gene in uterine leiomyomas. Oncogene 1997;14: 2355-65.
29. Sweetser DA, Chen CS, Blomberg AA, Flowers DA, Galipeau PC, Barret MT, et al. Loss of hererozygosity in childhood de novo acute myelogenous leukemia. Blood 2001;98:1188-94.
30. Pabst T, Schwaller J, Bellomo MJ, Oestreicher M, Muhlematter D, Tichelli A, et al. Frequent clonal loss of heterozygosity but scarcity of microsatellite instability at chromosomal breakpoint cluster regions in adult leukaemias. Blood 1996;88:1026-34.
31. Hatta Y, Yamada Y, Tomonaga M, Said JW, Miyosi I, Koeffler P. Allelotype analysis of adult T-cell Leukaemia. Blood 1998; 92:2113-7.
32. Kiuru-Kuhlefelt S, Kristo P, Ruutu T, Knuutila S, Kere J. Evidence for two molecular steps in the pathogenesis of myeloid disorders associated with deletion of chromosome 7 long arm. Leukemia 1997;11:2097-104.
33. Tripputi P, Cassani B, Alfano R, Graziani D, Cicognini D, Doi P, et al. Chromosome 7 monosomy and deletions in myeloproliferative disease. Leuk Res 2001;25:735-9.
34. Koike M, Tasaka T, Spira S, Tsuruoka N, Koeffler HP. Allelotyping of acute myelogenous leukemia: loss of heterozygosity at 7q31.1 (D78S486) and q33-34 (D7S498, D7S505). Leuk Res 1999;23:307-10.
35. Rigolin GM, Bigoni R, Milani R, Cavazzini F, Roberti MG, Bardi A, et al. Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype. Leukemia 2001;15:1841-7.
36. Haydon AM, Jass JR. Emerging pathways in colorectal-cancer development. Lancet Oncol 2002;3:83-8.
37. Starostik P, Muller-Hermelink HK. Diagnosis of microsatellite instability-positive colorectal cancer. Expert Rev Mol Diagn 2001;1:71-80.
38. Achille A, Biasi MO, Zamboni G, Bogina G, Iacono C, Talamini G, et al. Cancers of the papilla of vater: mutator phenotype is associated with good prognosis. Clin Cancer Res 1997;3:1841-7.
39. Tasaka T, Lee S, Spira S, Takeuki S, Hatta Y, Nagai M, et al. Infrequent microsatellite instability during the evolution of the myelodysplastic syndrome to acute myelocytic leukaemia. Leuk Res 1996;20:113-7.
40. Brown AG, Ross FM, Dunne EM, Steel CM, Weir-Thompson EM. Evidence for a new tumor suppressor locus (DBM) in human B-cell neoplasia telomeric to the retinoblastoma gene. Nat Genet 1993;3:67-72.
41. Stilgenbauer S, Schaffner C, Litterst A, Liebisch P, Gilad S, Bar-Shira A, et al. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nat Med 1997;3:1155-9.
42. Sinclair PB, Nacheva EP, Leversha M, Telford N, Chang J, Reid A, et al. Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukaemia. Blood 2000;95:738-43.
43. Kolomietz E, Al-Maghrabi J, Brennan S, Karaskova J, Minkin S, Lipton J, et al. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood 2001;97:3581-8.
44. Martinet D, Muhlematter D, Leeman M, ParlierV, Hess U, Gmur J, et al. Detection of 16p deletions by FISH in patients with inv(16) or t(16;16) and acute myeloid leukaemia (AML). Leukaemia 1997;11:964-70.
45. Van Der Kolk DM, Vellenga E, Van Der Veen AY, Noordhoek L, Timmer-Bosscha H, Ossenkoppele GJ, et al. Deletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia: the impact on MRP activity. Blood 2000;95:3514-9.
46. Marlton P, Claxton DF, Liu P, Estey EH, Beran M, Le Beau M, et al. Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesis. Blood 1995;85:772-9.
47. Corral J, Forster A, Thompson S, Lampert F, Kaneko Y, Slater R, et al. Acute leukemia of different lineage have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation. Proc Natl Acad Sci USA 1993;90: 8538-42.
48. Aoki K, Suzuki K, Sugano T, Tasaka T, Nakahara K, Kuge O, et al. A novel gene, Translin, encodes a recombination hotspot binding protein associated with chromosomal translocations. Nat Genet 1995;10:167-74.
49. Glover TW, Stein CK. Chromosome breakage and recombination at fragile sites. Am J Hum Genet 1988;43:265-73.
50. Hule ML, Shanske AL, Kasper JS, Marion RW, Hirschhorn R. A large Alu-mediated deletion, identified by PCR, as the molecular basis for glycogen storage disease type II (GSDII). Hum Genet 1999;104:94-8.